Page last updated: 2024-09-05

tesaglitazar and Diabetic Angiopathies

tesaglitazar has been researched along with Diabetic Angiopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farkouh, M; Plutzky, J; Rosenson, RS; Wright, RS1

Reviews

1 review(s) available for tesaglitazar and Diabetic Angiopathies

ArticleYear
Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects.
    American heart journal, 2012, Volume: 164, Issue:5

    Topics: Alkanesulfonates; Diabetic Angiopathies; Glycine; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Oxazines; Oxazoles; Phenylpropionates; Phosphorylation; PPAR alpha; PPAR delta; PPAR gamma; Thiazolidinediones; Thiophenes; United States; United States Food and Drug Administration

2012